The next challenger for Chris Weidman’s middleweight title has been announced.

Facing off with Weidman at UFC 181 on Saturday, Dec. 6 will be former light heavyweight champion Vitor Belfort.

The news came following Wednesday’s Nevada State Athletic Commission (NSAC) meeting which resulted in the commission granting Belfort a conditional license to compete in the state.

Belfort has been a lightning rod of controversy since it was revealed he was undergoing testosterone-replacement therapy (TRT). The Brazilian tested positive for steroid use in 2006 and was subsequently fined and suspended by the NSAC. Belfort has not competed in the US, nor Nevada, since 2011. However, the 36-year-old was confident that he would receive a therapeutic-use exemptions (TUE) for a planned bout with Weidman at UFC 173 in May. However, Belfort admitted to a failed drug test for elevated levels of testosterone prior to the bout and was pulled from the contest. Now that his issues with the NSAC are resolved, he will once again challenge for UFC gold.

For Weidman, the bout will mark the third defense of his middleweight title. The unbeaten New Yorker captured the belt with a second-round knockout of long-reigning champion Anderson Silva at UFC 162, then retained it in the pair’s rematch in December at UFC 168, before besting former light heavyweight champion Lyoto Machida at UFC 175 on July 5.

UFC 181 takes place from the Mandalay Bay Event Center in Las Vegas and airs live on pay-per-view. More bouts for the event are expected to announced by the promotion in the coming months.